Microvascular angina Flashcards

1
Q

define angina pectoris

A

Angina is traditionally defined as central chest discomfort (pain or tightness) of less than 10 minutes’ duration. This discomfort is provoked by exertion or emotional stress and is relieved by rest or by administration of nitroglycerin. In this typical form, angina is suggestive of obstructive coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does NICE define stable angina as?

A
  1. Constricting discomfort in the front of the chest, neck, shoulders, jaw, or arms.
  2. Precipitated by physical exertion.
  3. Relieved by rest or GTN within about 5 minutes.

People with typical angina have all three of the above

People with atypical angina have two, and people with non-anginal chest pain have one or none of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a strong predictor of the presence of coronary artery disease?

A

Typical chest pain is a strong predictor of the presence of coronary artery disease.

Non-anginal chest pain (i.e pain unrelated to activity, not relieved by rest or GTN, and not suggestive of angina) is an important predictor for ruling out CAD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the term angina pectoris synonymous with?

A

obstructive atherosclerotic epicardial CAD (coronary artery disease).

The main cause for myocardial ischaemia in clinical practice is considered to be obstructive CAD

Current diagnostic and therapeutic strategies for angina are based on this paradigm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is considered the angina universe?

A

Coronary atheroma: STEMI, NSTEMI, ACS, CSA, graft stenosis, stent stenosis.

Vasospastic angina: variant angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does myocardial ischemia result from?

A

a mismatch between myocardial oxygen demand and coronary blood flow (supply limited by coronary atherosclerosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Patients and physicians frequently view coronary artery stenosis as a mechanical problem that can be “fixed” by mechanical means.

what is the management of IHD based on?

A

the paradigm that myocardial ischaemia is almost always caused by atheromatous CAD-

[angiogram] CAD in the absence of myocardial ischaemia= false negative

Ischaemia in the absence of CAD= false positive

Orbita study showed that in stable angina patients: angioplasty is not better than placebo! (not the case for acute coronary syndrome- angioplasty may be required)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

if the plaque is not the centre of the “universe” (occlusive CAD), what can trigger myocardial ischaemia?

A

Problems with the coronary microcirculation:

•Structural mechanisms-->
o Adverse arteriolar remodelling:
- Increased medial wall thickness
- Intimal thickening 
- Reduced wall/lumen ration 

o Intravascular plugging
o Perivascular fibrosis
o Capillary rarefaction

•Functional mechanisms–>
o Microvascular spasm
o Abnormal vasodilation
o Endothelial dysfunction and/or VSMC dysfunction

Microvascular angina as a cause of chest pain with angiographically normal coronary arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the myocardial factors affecting microvascular function?

A
  • Left ventricular hypertrophy
  • Reduced diastolic time
  • Calcium overload
  • Amyloidosis
  • Increased intramyocardial pressure
  • Increased intracavitary pressure
  • Tissue edema

Coronary microvascular dysfunction leads to transient myocardial ischaemia- “Microvascular angina”:
the coronary microcirculation has remained elusive to conventional imaging techniques for decades

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is microvascular angina?

A

Markedly increased resistance to coronary blood flow at the site of the coronary microvasculature can trigger myocardial ischaemia, as shown by ECG shifts, myocardial perfusion defects and LV dysfunction in patients who otherwise have patent epicardial coronary arteries.

Hermann J, Kaski JC, Lerman A. Eur Heart J 2012.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

microvascular angina (Cardiac syndrome X) is mainly seen in who?

A

menopausal women

  • Typical exertional/rest chest pain*
  • Transient ischaemic ECG changes
  • Normal coronary arteriograms

More prevalent in women in most series; >50% have documented myocardial ischaemia and >50% coronary microvascular endothelial dysfunction leading to abnormal MV dilatation and ischaemia
JC Kaski. Circulation 2004

Estrogen deficiency must have also played a part as mainly in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what did Jaskanwal D. Sara et al’s study on the prevalence of coronary microvascular dysfunction among patients with chest pain and non-obstructive coronary artery disease show?

A
  • 60% of people who were sent for angiography due to angina= had normal arteries
  • What proportion of those had abnormalities in the coronary microvessels?
  • Showed that 60% of those with normal arteries + angina had abnormalities in the coronary microvessels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the diagnostic criteria for microvascular angina?

A

COVADIS (Coronary Vasomotion Disorders International Study Group)

  • Signs/symptoms of angina
  • Absence of obstructive CAD*
  • Objective evidence of myocardial ischaemia
  • Coronary microvascular dysfunction (CFR <2.5/MV spasm)

Ong P, Camici PG, Beltrame JF, Crea F, Shimokawa H, Sechtem U, Kaski JC, Bairey Merz N, International standardization of diagnostic criteria for microvascular angina. Int J Cardiol 2017

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Coronary microvascular dysfunction (CMD) is one reason why there is a high prevalence of angina/myocardial ischaemia which is not caused by obstructive CAD. Describe its presentation

A

No CAD - “Primary MVA” (“Cardiac Syndrome X”):
- Systemic hypertension, dyslipidaemia, smoking, diabetes, oestrogen deficiency, Cardiomyopathies, LVH- left ventricular hypertrophy, amyloid disease, AS.

  • Amyloid disease: can have deposits of the abnormal protein in the microvessels–> embolus
  • Left ventricular hypertrophy: have less capillaries than normal + have compressive effect on the microvessels

SLE and Rheumatoid Arthritis:
Inflammation–> vasoconstriction–> endothelial damage–> ischaemia (even in the absence of CAD)–> affect microvessels

ACS (acute coronary syndrome)– MINOCA, Takotsubo syndrome, no reflow:

  • Arteries are normal in some cases
  • Ventricle has a peculiar shape: takotsubo syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

does PCI (Percutaneous Coronary Intervention- formerly known as angioplasty with stent) help microvascular angina?

A

(Li Y et al. Can J Cardiol 2015):

  • Coronary flow reserve (CFR) and hyperaemic index of myocardial resistance (IMR) assessed in 39 patients with chest pain and 12 asymptomatic patients after PCI-stenting; all without restenosis. The culprit vessel and a reference artery were assessed.
  • Symptomatic patients had lower CFR* and higher IMR in both, culprit and reference arteries (*54% with CFR <2.5).

Mechanisms:

  • Microembolism (platelets / microparticles)
  • Ischemia-reperfusion injury (endothelial damage due to increase in proinflammatory molecules)
  • Increase in reactive oxygen species
  • Decreased NO activity
  • Abnormal microvascular remodeling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the functional causes of microvascular angina?

A

Impaired coronary microvascular dilatation reduces CFR and causes exertional angina. Microvascular spasm can cause rest angina – Kaski JC. Circulation 2004

Either arteries can’t vasodilate (may have plaque), or they go into spasm

Symptoms of impaired vasodilation:
-	Exertional angina
-	Normal arteries but have ischaemia 
Coronary spasm:
-	Unstable angina
17
Q

what is the difference between coronary spasm and microvascular spasm?

A

Coronary spasm:
Patient comes with chest pain–> sent for a coronary angiography–> inject acetylcholine into the coronary arteries–> artery disappeared–>Gave nitrate into the coronary artery= diameter of artery went back to normal, pain dissipated, ECG change disappeared

Microvascular spasm:
Injected ach–> didn’t see any change in coronary artery diameter but patient had angina and typical ECG changes of ischaemia–> gave intracoronary nitrates–> pain and ECG change disappeared.
• No change in the epicardial diameter but constriction of the microvessels.

When patients go into spasm: cardiac troponin increases–> suggests that cell damage must occur

18
Q

why is there a need for identifying ischaemia in patients with angina and no obstructive CAD?

A
  • Poor quality of life
  • MACE, 2.5% annual rate (a lot of money spent on angiograms thinking that may have missed obstructive plaque etc)
  • 10% have prior subclinical MI which predicts MACE
  • Healthcare spending similar to that in obstructive CAD
  • Patients receive inappropriate treatment

Shaw, Bairey Merz et al. JACC 2009;
Wei et al. JACC 2015

19
Q

what does the angina universe have to include too?

A

coronary microvascular dysfunction too!

20
Q

why is it important to incorporate microvascular angina in the angina universe?

A

Incorporating microvascular angina is important because you breach the gap between the 2 extremes (CAD related angina and vasospastic angina) and are able to provide rational treatment for them.

Microvascular angina:

  • abnormal coronary microvascular dilation
  • microvascular spasm
21
Q

how is microvascular angina treated?

A

Improve endothelial function (Risk factors, statins, exercise, ACEI, Oestrogen).

Angina/Ischaemia – CCB and BB useful in effort-induced MVA and vasodilators (nitrates, nicorandil, CCB) for microvascular spasm.

Tackle cardiometabolic issues (Metformin, ranolazine and trimetazidine).

Pain management (Imipramine, aminophylline, TENS, SCS).

Psychological mechanisms

22
Q

describe the pharmacological therapy for MVA

A
  • Robust evidence for the treatment of microvascular angina is largely lacking at present.
  • Studies in most cases have been carried out in small numbers of patients.
  • The effect of treatment in many studies may be diluted by enrolment of patients with different pathophysiologic mechanisms of MVA.
  • Current ESC guidelines provide recommendations based on a “first line “ and “second line” concept that has flaws.
23
Q

describe the treatment targets of primary microvascular angina

A

Increased MVO2 demand (tachycardia, high BP): beta-blockers, CCBs, ivabradine.

Coronary artery spasm: nitrates- CCBs, nicorandil, Rho-K I

Impaired coronary microvascular dilation (risk factors, oestrogen deficiency, endothelial dysfunction): Nitrates, CCBs, nicorandil-oestrogen

Heart metabolic abnormalities: ranolazine, metformin, trimetazidine

effects of ischaemia per se (microvascular compression): ranolazine

inflammation: statins, colchicine, ?biologicals

24
Q

explain some of these treatments

A

• Need to reduce increased MVO2 demand (want to avoid tachycardia and high BP)
 Use beta blockers if no spasm
 Ivabradine slows down the heartbeat
• Metformin improves endothelial function
• Ranolazine is a blocker of the sodium current, has a protective effect on heart muscle- reduces stiffness